Within the neuralgia treatment market, Surgery held a 62.86% share in 2025, reflecting its established role in cases where long-term pain control requires direct procedural intervention. its position is underpinned by the fact that surgery is typically used for patients with severe or persistent neuralgia who do not achieve sufficient relief through conservative management. That practical treatment pathway supports higher procedural reliance, especially when clinicians aim to address the underlying pain source rather than manage symptoms alone.

Drug Based treatment is the fastest-growing segment in the neuralgia treatment market because it aligns with the need for more accessible and less invasive pain management options. Growth is being reinforced through wider preference for earlier therapeutic intervention before procedural escalation, as well as the practicality of drug-based care in ongoing symptom control. Compared with surgery, this segment is gaining momentum through broader applicability across patient settings and treatment stages, making it a more scalable option as neuralgia diagnosis and management expand.

End Use Segment Analysis: Hospitals & Clinics (Largest Segment) vs Ambulatory Surgery Centers (Fastest-Growing Segment)

Hospitals & Clinics accounted for the largest share of the neuralgia treatment market in 2025, reinforced through their central role in diagnosis, multidisciplinary evaluation, and treatment delivery across both medical and surgical pathways. Their leadership remains rooted in the ability to manage complex neuralgia cases within a single care setting, including specialist consultation, imaging, medication management, and procedural support. This concentration of clinical capabilities helps Hospitals & Clinics retain the leading share in a market where treatment often requires coordinated care.

Ambulatory Surgery Centers are emerging as the fastest-growing end-use segment in the neuralgia treatment market as care delivery increasingly shifts toward efficient outpatient procedural settings. Their momentum is influenced by the practical appeal of handling eligible interventions with streamlined workflows and reduced facility burden compared with traditional hospital environments. Relative to other end-use settings, Ambulatory Surgery Centers are benefiting from demand for more convenient treatment access where neuralgia procedures can be performed without the full infrastructure of inpatient care.